主权项 |
1. A method for the production of hydrogen comprising
(a) dehydrocoupling at least one amine-borane of the formula (I)
R1R2N—BHR3R4 (I) wherein R1, R2, R3 and R4 are each simultaneously or independently selected from H, fluoro-substituted-C1-20alkyl, optionally substituted C1-20alkyl and optionally substituted C6-14aryl or any two of R1, R2, R3 and R4 are linked to form an optionally substituted C2-10alkylene, which together with the nitrogen and/or boron atoms to which they are attached, forms a ring, wherein the optional substituents are independently selected from one or more of C1-6alkyl, halo, halo-substituted C1-6alkyl, C3-10cycloalkyl, aryl and heteroaryl, in the presence of at least one ligand-stabilized metal catalyst in an inert solvent and, optionally, in the presence of a base, wherein the metal catalyst comprises at least one ligand that bonds to the metal through a nitrogen; and (b) optionally collecting hydrogen produced in the dehydrocoupling of the at least one amine borane, wherein the at least one ligand that bonds to the metal through a nitrogen is selected from one or more of an N2, PN, PNP, PNNP, NPN, NS and NNN ligand wherein N2 is a bidentate ligand of the formula R5R6N-Q1-NR7R8; PN is a bindante ligand of the formula R9R10P-Q2-NR11R12; PNP is a tridentate ligand of the formula R13R14P-Q3-NR15-Q4-PR16R17; PNNP is a tetradentate ligand of the formula R18R19P-Q5-NR20-Q6-NR21-Q7-PR22R23; NPN is a tridentate ligand of the formula R24R25N-Q8-PR26-Q9-NR27R28; NS is a bidentate ligand of the formula R29R30N-Q10-SR31; and NNN is a tridentate ligand of the formula R32R33N-Q11-NR34-Q12-NR35R36, wherein R5-R36 are independently selected from unsubstituted or substituted C1-10alkyl, unsubstituted or substituted C2-10alkenyl, unsubstituted or substituted C3-10cycloalkyl, unsubstituted or substituted C6-14aryl, or any two adjacent or geminal R5-R36 groups are bonded together to form, together with the atoms to which they are attached, a 5-14-membered monocyclic, polycyclic, heterocyclic, carbocyclic, saturated or unsaturated ring system and any of R5-R36, including rings formed therewith are achiral or chiral; and Q1-Q12 are independently selected from unsubstituted or substituted C1-C10alkylene and unsubstituted or substituted C1-C10alkenylene where adjacent or geminal substituents on Q1-Q12 are joined together to form, including the atoms to which they are attached, one or more unsubstituted or substituted 5-14-membered monocyclic, polycyclic, heterocyclic, carbocyclic, saturated, unsaturated or metallocenyl ring systems, and/or one or more of the carbon atoms in Q1-Q12 is optionally replaced with a heteromoiety selected from O, S, NH and N(C1-6alkyl) and any of Q1-Q12 is chiral or achiral, and wherein the optional substituents are independently selected from one or more of C1-6alkyl, halo, halo-substituted C1-6alkyl, C3-10cycloalkyl, aryl and heteroaryl. |